SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

Tag: “Medication

Tag Search

visual bubble
visual bubble
visual bubble
visual bubble

SCCM Pod-504 CCM: Baricitinib or Tocilizumab for Severe COVID-19

Host Marilyn N. Bulloch, PharmD, BCPS, FCCM, is joined by Joy Peterson, PharmD, BCPS, BCIDP, and Neha Paranjape, MD, MPH, to discuss the Critical Care Medicine article, "Outcomes and Adverse Effects of Baricitinib Versus Tocilizumab in the Management of Severe COVID-19,” which delves into the comparative outcomes, mortality rates, and adverse effects of baricitinib and tocilizumab in severe COVID-19 cases.